Rhythm Biosciences Limited (ASX:RHY)
Australia
· Delayed Price · Currency is AUD
0.0640
0.00 (0.00%)
May 15, 2025, 10:11 AM AEST
Rhythm Biosciences Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
Net Income | -2.18 | -6.86 | -8.22 | -8.79 | -6.61 | -4.02 | |
Depreciation & Amortization | 0.19 | 0.2 | 0.19 | 0.1 | 0.15 | 0.14 | |
Stock-Based Compensation | -1.05 | -1.05 | 3 | 2.61 | 0.56 | 0.02 | |
Other Operating Activities | -0.65 | - | - | - | - | 0.08 | |
Change in Accounts Receivable | -1.03 | -1.03 | 0.91 | -0.48 | -0.04 | 0.66 | |
Change in Inventory | 2.77 | 2.77 | -2.77 | - | - | - | |
Change in Accounts Payable | - | - | - | - | 0.51 | 0.36 | |
Change in Other Net Operating Assets | -0.16 | -0.16 | -0.08 | 0.07 | 0.04 | 0.02 | |
Operating Cash Flow | -2.12 | -6.14 | -6.96 | -6.5 | -5.4 | -2.74 | |
Capital Expenditures | -0 | -0.08 | -0.1 | -0.03 | -0.07 | -0.05 | |
Investment in Securities | -0.04 | - | - | - | - | - | |
Investing Cash Flow | -0.56 | -0.08 | -0.1 | -0.03 | -0.07 | -0.05 | |
Long-Term Debt Repaid | - | -0.09 | -0.09 | -0.01 | -0.04 | -0.14 | |
Net Debt Issued (Repaid) | -0.08 | -0.09 | -0.09 | -0.01 | -0.04 | -0.14 | |
Issuance of Common Stock | 6.25 | 3.02 | 3.74 | 12.32 | 6.17 | - | |
Other Financing Activities | -0.34 | -0.12 | -0.02 | -0.47 | -0.23 | - | |
Financing Cash Flow | 5.83 | 2.8 | 3.63 | 11.85 | 5.9 | -0.14 | |
Net Cash Flow | 3.15 | -3.41 | -3.43 | 5.32 | 0.43 | -2.93 | |
Free Cash Flow | -2.12 | -6.22 | -7.06 | -6.52 | -5.47 | -2.79 | |
Free Cash Flow Margin | -66.92% | -367.98% | -227.94% | -268.74% | -493.52% | -2788.13% | |
Free Cash Flow Per Share | -0.01 | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 | |
Cash Interest Paid | 0.06 | 0 | 0.01 | - | 0 | 0.01 | |
Cash Income Tax Paid | - | -1.69 | -3.08 | -2.41 | -1.11 | -0.74 | |
Levered Free Cash Flow | -2.23 | -3.63 | -4.12 | -3.28 | -2.97 | -1.38 | |
Unlevered Free Cash Flow | -2.19 | -3.63 | -4.12 | -3.28 | -2.97 | -1.38 | |
Change in Net Working Capital | 0 | -1.62 | 1.94 | 0.45 | -0.53 | -1.05 | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.